Abiopharma

FUTUREFUEL CORP. (FF) Reports the reporting period Financial Results FUTUREFUEL CORP. (FF) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 78726
• Net Income: 11370
• EPS: Not disclosed
• Cash and equivalents: 34366
  • faceted strategy to drive long
  • term value creation, anchored by profitable organic and inorganic growth across its core Chemicals and Biofuels segments, enhanced operational discipline in areas such as plant optimization, procurement, and automation, and a returns
  • focused capital allocation framework that balances reinvestment in the business with shareholder returns, including share repurchases under its existing authorization and a quarterly cash dividend. In the second quarter of 2026, the Company advanced this strategy through the following key actions outlined below. ● Strengthening demand, new program wins support improved Chemicals segment utilization. Chemicals segment plant utilization, as defined by production divided by nameplate capacity, increased to 65% in the second quarter of 2026, versus 54% in the prior